Loading...
  • patients
  • Our aim is to determine if carer-administration of as-needed subcutaneous medication for four frequent breakthrough symptoms (pain, nausea, restlessness and noisy breathing) in home-based dying patients is feasible and acceptable in the UK. (springer.com)
  • Dyads of adult patients/carers are eligible, where patients are in the last weeks of life and wish to die at home, and lay carers who are willing to be trained to give subcutaneous medication. (springer.com)
  • The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. (bio-medicine.org)
  • Patients with severe neurological deficits should not self‐administer injections without assistance from a trained caregiver. (bioportfolio.com)
  • f) Advise patients and caregivers to rotate sites for subcutaneous injections to minimize the likelihood of severe injection site reactions, including necrosis or localized infection. (bioportfolio.com)
  • Glatiramer acetate injection is indicated for the treatment of patients with relapsing-forms of multiple sclerosis ( 1 ). (nih.gov)
  • Glatiramer acetate injection is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol. (nih.gov)
  • By testing gradually higher daily dosages of IL-2 in different groups of patients, the investigators also established that intermittent cycles of subcutaneous IL-2 therapy can be self-administered safely at a maximum tolerated dose of 15 million international units (MIU) per day. (nih.gov)
  • To determine how much drug patients could tolerate, the investigators started the first group of patients on low-dose (3 MIU) subcutaneous IL-2, and gradually increased the dosage in subsequent groups of patients until serious toxicities arose. (nih.gov)
  • In extended follow-up, eight patients have remained on subcutaneous IL-2 therapy for more than three years. (nih.gov)
  • breath , facial swelling, headache, chills, back pain, tightness in the chest or throat, and/or hypotension occurred in 11% of patients with solid tumors treated with doxorubicin hydrochloride liposome injection. (bioportfolio.com)
  • Doxorubicin hydrochloride liposome injection is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy. (bioportfolio.com)
  • Doxorubicin hydrochloride liposome injection is indicated for the treatment of AIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy or intolerance to such therapy. (bioportfolio.com)
  • Doxorubicin hydrochloride liposome injection, in combination with bortezomib, is indicated for the treatment of patients with multiple myeloma who have not previously received bortezomib and have received at least one prior therapy. (bioportfolio.com)
  • HealthDay News) - Subcutaneous botulinum toxin type A (BTX-A) injections appear to safely and effectively reduce chronic neuropathic pain in patients with spinal cord injury, according to a study published online Jan. 27 in the Annals of Neurology . (empr.com)
  • Zee-A Han, M.D., Ph.D., from the National Rehabilitation Center in Seoul, South Korea, and colleagues evaluated a one-time subcutaneous BTX-A (200 units) injection in 40 patients with spinal cord injury-associated neuropathic pain. (empr.com)
  • Patients administered the 120-mg/m regimen of epirubicin hydrochloride injection should receive prophylactic antibiotic therapy. (bioportfolio.com)
  • For patients receiving a divided dose of epirubicin hydrochloride injection (Day 1 and Day 8), the Day 8 dose should be 75% of Day 1 if platelet counts are 75,000-100,000/mm and ANC is 1000 to 1499/mm. (bioportfolio.com)
  • As it is not known whether various r-HuEpo products can be safely interchanged, we studied 30 patients with chronic kidney disease treated by subcutaneous injection with biosimilar r-HuEpo and who developed a sudden loss of efficacy. (ebscohost.com)
  • Recent reports indicate that the majority of these patients do not have to be hospitalized: they can be safely treated at home, which will result in a tremendous decrease in our health care costs. (amjmed.org)
  • One of the first reports that many patients with acute pulmonary embolism can safely be treated at home with subcutaneous injections of low-molecular-weight heparin (LMWH) and oral warfarin appeared in 1998. (amjmed.org)
  • The pulmonary embolism patients who can safely be treated at home are low-risk patients who are not in shock, do not require supplemental oxygen or parenteral narcotics for pain, and do not have other conditions that require hospitalization. (amjmed.org)
  • Advise patients to seek medical care if they develop signs or symptoms of infection at the epinephrine injection site. (nih.gov)
  • 5% of patients treated with REPATHA and occurring more frequently than placebo): nasopharyngitis, upper respiratory tract infection, influenza, back pain, and injection site reactions. (nih.gov)
  • RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. (nih.gov)
  • Use the vial for patients who require other doses of RELISTOR injection. (nih.gov)
  • Epinephrine injection, USP auto-injector is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. (nih.gov)
  • Instruct patients to check insulin labels before injection. (lilly.com)
  • Train patients on proper use and injection technique before initiating BASAGLAR. (lilly.com)
  • In patients with a low to moderate risk of venous thromboembolism the recommended dosage is 20mg (2,000IU) once daily by subcutaneous injection for 7 to 10 days, or until the risk of thromboembolism has diminished. (drugs.com)
  • In patients with a higher risk, such as in orthopaedic surgery, the dosage should be 40mg (4,000IU) daily by subcutaneous injection with the initial dose administered approximately 12 hours before surgery. (drugs.com)
  • In patients with a high-risk of venous thromboembolism who undergo abdominal or pelvic surgery for cancer and are not otherwise at risk for major bleeding complications, the recommended dosage is 40mg (4,000IU) once daily by subcutaneous injection for 4 weeks with the initial dose administered approximately 12 hours before surgery. (drugs.com)
  • A non-invasive diagnostic test that could reliably assess subcutaneous, peripheral contributors to a patient's pain would be extremely helpful for diagnosing and treating patients with pain of unknown origin. (biomedcentral.com)
  • dose
  • In a dose-ranging pharmacokinetic (PK) and pharmacodynamic trial, bolus SC injections of 75, 150 and 225 mg yielded dose-proportional plasma concentrations that were associated with down-regulation of Bcl-2 in blood cells. (bio-medicine.org)
  • The next injection should be taken about 48 hours (two days) after that dose. (bioportfolio.com)
  • Before injecting each dose, clean the injection site with rubbing alcohol. (webmd.com)
  • cancer who were treated with doxorubicin hydrochloride liposome injection, the risk of cardiotoxicity was 11% when the cumulative anthracycline dose was between 450 to 550 mg/m. (bioportfolio.com)
  • The recommended dose of doxorubicin hydrochloride liposome injection is 50 mg/m intravenously over 60 minutes every 28 days until disease progression or unacceptable toxicity. (bioportfolio.com)
  • The recommended dose of doxorubicin hydrochloride liposome injection is 30 mg/m intravenously over 60 minutes on day 4 of each 21-day cycle for eight cycles or until disease progression or unacceptable toxicity. (bioportfolio.com)
  • Do not increase doxorubicin hydrochloride liposome injection after a dose reduction for toxicity. (bioportfolio.com)
  • The total dose of epirubicin hydrochloride injection may be given on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle. (bioportfolio.com)
  • The recommended dose of epirubicin hydrochloride injection is 100 to 120 mg/m. (bioportfolio.com)
  • For injection: 1 mg of glucagon as powder for reconstitution in a single dose vial, alone or co-packaged with Sterile Water for Reconstitution. (nih.gov)
  • The recommended dose of enoxaparin sodium is 40mg (4,000IU) once daily by subcutaneous injection. (drugs.com)
  • heparin
  • Do not mix epirubicin hydrochloride injection with heparin or fluorouracil due to chemical incompatibility that may lead to precipitation. (bioportfolio.com)
  • Placebo
  • CAM2038 placebo: 0.16, 0.32, 0.48 and 0.64 mL SC injection administered once weekly or once monthly (matching volumes for CAM2038 q1w and near-matching volumes for CAM2038 q4w). (clinicaltrials.gov)
  • During Phase 2, subjects in Group 1 will continue treatment with monthly dispensing of daily SL BPN treatment and monthly placebo SC injections, and subjects in Group 2 (receiving CAM2038 q1w) will be transferred to monthly injections of CAM2038 q4w and monthly dispensing of daily SL placebo. (clinicaltrials.gov)
  • regimen
  • The subcutaneous regimen represents an improvement, however, because the side effects are less severe and less prolonged, and the treatment can be administered by the patient at home. (nih.gov)
  • symptoms
  • When Testosterone injections are prescribed by your doctor, you can start your androgen replacement program and alleviate symptoms associated with Low T, Erectile Dysfunction or Deficient Testosterone levels . (rxhghtherapy.com)
  • Hormone
  • Use the Quick Info Form for finding Testosterone Specialists, Hormone Doctors & Clinics, Age Management Physicians and Medical Spas that prescribe Testosterone injections. (rxhghtherapy.com)
  • We offer the greatest variety of Testosterone Hormone injections and treatment methods. (rxhghtherapy.com)
  • The calories you eat combined with the ones released by the hormone will help you safely lose weight while maintaining a normal energy level. (wayzatacosmeticsurgery.com)
  • treatment
  • Pain and quality of life assessments were made before treatment and at four weeks and eight weeks after the injection. (empr.com)
  • www.RXHGHTherapy.com is one of the best testosterone treatment resources online in the United States for getting doctor prescribed Testosterone injections . (rxhghtherapy.com)
  • SUPPRELIN LA (histrelin acetate) subcutaneous implant is indicated for the treatment of children with central precocious puberty (CPP). (endo.com)
  • inhibits
  • A pilot study of the in vivo potency of LeTx by Koo and colleagues showed that the i.t. injection of LeTx inhibits tumor growth in a mouse xenograft melanoma model ( 16 ). (aacrjournals.org)
  • increases
  • As reported in the April issue of the Journal of Infectious Diseases, investigators at the National Institutes of Health (NIH) have found that self-administered injections of the immune system protein interleukin-2 (IL-2) can produce prolonged, dramatic increases in levels of CD4+ T cells in some people infected with HIV. (nih.gov)